Willard is a clinician, health economist and former intelligence professional. He works directly with your executive team to navigate complexity, drive growth, and help make confident decisions.
For pharmaceutical clients, I make sense of economic and industry trends, explain their implications for business revenues and growth, and develop practical strategies to respond.
I develop innovative, data-driven thought leadership to help set strategic agendas within organizations and in public.
I leverage subject-matter expertise and apply economic analysis tools and techniques to generate evidence that helps the CEO office understand the implications of future and past decisions.
I undertake systematic assessments of the positive and negative effects of proposed and existing regulations, and of non-regulatory alternatives, to address the pharmaceutical/public policy issues at hand.
I leverage business-case best practices to help the CEO office build convincing, evidence-based business cases for investment, infrastructure, and public-policy proposals.
I analyze therapy areas end to end—mapping the science, standard of care, pipeline, guideline shifts, and competitor moves. I quantify patient flow, unmet need, and access headroom, and deliver market models, preparing you to make a decision.
